Abstract
The authors report a case of reduction of thyrotoxicosis-related atrial fibrillation by cibenzoline. The initial clinical features of heart failure rapidly resolved and the echocardiographic left ventricular shortening fraction returned to normal. Cibenzoline could be used as antiarrhythmic treatment in atrial fibrillation related to thyrotoxicosis.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Anti-Arrhythmia Agents / pharmacology
-
Anti-Arrhythmia Agents / therapeutic use*
-
Atrial Fibrillation / diagnosis
-
Atrial Fibrillation / drug therapy*
-
Atrial Fibrillation / etiology*
-
Atrial Fibrillation / physiopathology
-
Electrocardiography
-
Female
-
Humans
-
Imidazoles / pharmacology
-
Imidazoles / therapeutic use*
-
Thyrotoxicosis / complications*
-
Treatment Outcome
-
Ventricular Function, Left / drug effects
Substances
-
Anti-Arrhythmia Agents
-
Imidazoles
-
cifenline